Published in Am J Transplant on September 10, 2008
Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2015) 2.80
Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am J Transplant (2011) 2.32
Lung transplant airway hypoxia: a diathesis to fibrosis? Am J Respir Crit Care Med (2010) 1.77
Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood (2011) 1.12
Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant (2011) 1.10
Primary graft dysfunction. Semin Respir Crit Care Med (2013) 0.93
Alloimmunity and autoimmunity in chronic rejection. Curr Opin Organ Transplant (2010) 0.93
CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction. Am J Respir Crit Care Med (2013) 0.89
Systemic sclerosis and bilateral lung transplantation: a single centre experience. Eur Respir J (2010) 0.86
Lung transplantation for cystic fibrosis. Proc Am Thorac Soc (2009) 0.83
Maintenance of IKKβ activity is necessary to protect lung grafts from acute injury. Transplantation (2011) 0.80
Update in lung transplantation 2013. Am J Respir Crit Care Med (2014) 0.80
Immediate postoperative inflammatory response predicts long-term outcome in lung-transplant recipients. Interact Cardiovasc Thorac Surg (2012) 0.79
Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation. Curr Opin Organ Transplant (2015) 0.78
Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications. Hum Immunol (2012) 0.78
Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study. Transplant Res (2014) 0.77
The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome. Am J Transplant (2015) 0.76
Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era. J Thorac Cardiovasc Surg (2011) 0.76
Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation. Am J Respir Cell Mol Biol (2016) 0.76
Donor lung derived myeloid and plasmacytoid dendritic cells differentially regulate T cell proliferation and cytokine production. Respir Res (2012) 0.76
Cumulative exposure to CD8+ granzyme Bhi T cells is associated with reduced lung function early after lung transplantation. Transplant Proc (2011) 0.75
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant (2002) 5.49
Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med (2003) 3.54
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant (1996) 3.51
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2005) 3.44
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 2.69
The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med (2005) 2.57
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med (2004) 1.95
De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol (2008) 1.95
Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Hum Pathol (1980) 1.89
Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant (2006) 1.72
Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol (2002) 1.68
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant (2007) 1.61
Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation (2002) 1.56
Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation (2007) 1.54
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. J Heart Lung Transplant (2005) 1.48
The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation (2005) 1.46
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46
Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc (2006) 1.35
Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol (2006) 1.31
Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg (2005) 1.29
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26
Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant (2006) 1.10
Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol (1993) 1.04
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J (2005) 1.01
Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg (2006) 1.01
Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg (1996) 1.00
The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. J Heart Lung Transplant (1996) 0.92
Immunoquantification of type I, III, IV and V collagen in small samples of human lung parenchyma. Int J Biochem Cell Biol (1995) 0.89
Association of humoral immunity and bronchiolitis obliterans syndrome. Am J Transplant (2003) 0.83
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med (1990) 2.85
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg (2001) 2.69
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1995) 2.44
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest (1998) 2.27
The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med (1999) 2.18
A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant (2007) 2.16
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg (1996) 2.15
Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant (1996) 1.94
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
Direct suppression of Stat1 function during adenoviral infection. Immunity (1998) 1.62
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg (1999) 1.59
Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation. Am J Transplant (2014) 1.56
Donor lung procurement: assessment and operative technique. Ann Thorac Surg (1993) 1.54
Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Lung volume reduction surgery: comparison of preoperative radiologic features and clinical outcome. Radiology (1997) 1.48
Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis. J Thromb Haemost (2013) 1.47
Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg (1986) 1.47
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg (2000) 1.46
Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg (1991) 1.46
Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg (1998) 1.45
Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger's syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1990) 1.42
Technology assessment and pneumoperitoneum therapy for air leaks and pleural spaces. Ann Thorac Surg (1997) 1.41
Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J Heart Lung Transplant (1997) 1.41
HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40
Preharvest nitroprusside flush improves posttransplantation lung function. J Heart Lung Transplant (1997) 1.40
A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant (2005) 1.39
Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. J Thromb Haemost (2012) 1.39
Strategies to increase limited donor resources. Eur Respir J (2004) 1.38
Separate extraction of cardiac and pulmonary grafts from a single organ donor. Ann Thorac Surg (1988) 1.37
Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg (1990) 1.36
Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function. Am J Pathol (2001) 1.32
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28
Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26
Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24
Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis (1989) 1.23
Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics (1983) 1.22
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22
Characterization of human IgG Fc receptors. J Immunol (1985) 1.21
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
Expression of a new cell surface antigen on activated murine macrophages. J Exp Med (1977) 1.21
Smoking cessation and lung cancer resection. Chest (1996) 1.21
Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery. Radiology (2001) 1.20
Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat (2004) 1.19
Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant (2012) 1.19
Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg (1997) 1.18
In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. Hum Immunol (2004) 1.17
CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation. Am J Transplant (2010) 1.17
Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res (1996) 1.17
Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula. Ann Thorac Surg (1981) 1.17
Spin Rabi flopping in the photocurrent of a polymer light-emitting diode. Nat Mater (2008) 1.16
Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis (1993) 1.16
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg (1995) 1.15
Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg (1999) 1.14
Surgeons' concern and practices of protection against bloodborne pathogens. Ann Surg (1998) 1.12
Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res (2003) 1.12
Experiences of women in cardiothoracic surgery. A gender comparison. Arch Surg (1996) 1.11
Cyclosporine in cardiac transplantation. Surg Clin North Am (1985) 1.11
Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1996) 1.10
Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg (1995) 1.10
Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant (2004) 1.09
Monoclonal antibody to human IgG Fc receptors. Cross-linking of receptors induces lysosomal enzyme release and superoxide generation by neutrophils. J Immunol (1988) 1.08
Redo lung transplantation: a North American-European experience. J Heart Lung Transplant (1993) 1.08
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1992) 1.08
Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Rev (Orlando) (1987) 1.08
Use of silicone stents in the management of airway problems. Ann Thorac Surg (1989) 1.08
Evaluation of a prototype esophageal detection device. Acad Emerg Med (1995) 1.07
Bronchial dehiscence in lung transplantation: CT evaluation. Radiology (1995) 1.07
Ex vivo adenoviral-mediated gene transfer to lung isografts during cold preservation. Ann Thorac Surg (1997) 1.07